Valuation: Becton, Dickinson and Company

Market Cap 42.13B 36.99B 34.05B 31.73B 59.83B 4,005B 61.05B 410B 159B 1,966B 158B 155B 6,843B P/E 2026 *
38.1x
P/E 2027 * 29.4x
Enterprise Value 58.09B 51B 46.94B 43.74B 82.49B 5,522B 84.17B 565B 219B 2,711B 218B 213B 9,434B EV / Sales 2026 *
3.02x
EV / Sales 2027 * 2.85x
Free-Float
74.04%
Yield 2026 *
2.52%
Yield 2027 * 2.56%
1 day+1.61%
1 week+2.21%
Current month+2.24%
1 month+7.13%
3 months+0.14%
6 months-20.63%
Current year-20.27%
1 week 149.69
Extreme 149.69
156.89
1 month 140.11
Extreme 140.11
156.89
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+1.67%+2.21%-12.72%-40.93% 42.13B
+1.80%+0.11%-30.40%-12.95% 161B
+2.39%+0.09%-8.71%-7.52% 101B
+2.01%+2.22%+0.74%+53.64% 56.12B
-1.22%-2.03%+54.34%+47.88% 53.35B
+1.74%+11.44% - - 35.29B
+2.86%+2.30%-15.97%-44.71% 26.57B
+0.16%+5.54%+65.34%-3.32% 25.79B
+1.00%+1.71%-10.09%-2.25% 20.69B
+2.69%+0.96%-12.07%-3.17% 19.59B
Average +1.46%+2.67%+3.38%-1.48% 54.15B
Weighted average by Cap. +1.55%+1.89%-5.03%-0.76%

Financials

2026 *2027 *
Net sales 19.21B 16.86B 15.52B 14.46B 27.28B 1,826B 27.83B 187B 72.33B 896B 72.11B 70.55B 3,119B 19.71B 17.31B 15.93B 14.84B 27.99B 1,874B 28.56B 192B 74.23B 920B 74.01B 72.41B 3,201B
Net income 1.12B 987M 909M 847M 1.6B 107B 1.63B 10.93B 4.24B 52.48B 4.22B 4.13B 183B 1.45B 1.27B 1.17B 1.09B 2.06B 138B 2.1B 14.09B 5.46B 67.63B 5.44B 5.32B 235B
Net Debt 15.95B 14.01B 12.89B 12.02B 22.66B 1,517B 23.12B 155B 60.09B 745B 59.91B 58.61B 2,591B 14.07B 12.36B 11.37B 10.6B 19.99B 1,338B 20.39B 137B 53B 657B 52.84B 51.69B 2,286B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
03/07/26 USD 154.73 +1.20% 419,302
01/07/26 USD 152.90 +1.04% 2,131,647
30/06/26 USD 151.33 -2.49% 2,109,075
29/06/26 USD 155.19 -0.47% 2,396,596
26/06/26 USD 155.92 +3.00% 12,180,748
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
152.90USD
Average target price
177.75USD
Spread / Average Target
+16.25%

Quarterly revenue - Rate of surprise